发明名称 |
WT1 anti-tumour vaccine adjuvanted with BCG-cell wall skeleton |
摘要 |
The present invention provides a novel method for inducing antigen-specific T cells. A method for inducing antigen-specific T cells in a patient comprising administering to said patient in need thereof composition (a) which comprises a therapeutically effective amount of an antigen protein or an antigen peptide as an active ingredient, and composition (b) which comprises a therapeutically effective amount of a cell wall skeleton integrant of the BCG strain of Mycobacterium bovis as an active ingredient, wherein composition (b) is administered in advance and then composition (a) is administered, and related pharmaceutical compositions are provided.
|
申请公布号 |
EP1447092(A1) |
申请公布日期 |
2004.08.18 |
申请号 |
EP20020800255 |
申请日期 |
2002.09.27 |
申请人 |
SUGIYAMA, HARUO;AZUMA, ICHIRO |
发明人 |
SUGIYAMA, HARUO;AZUMA, ICHIRO |
分类号 |
A61K39/00;A61P35/00;(IPC1-7):A61K39/00;A61K45/00 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|